EGM
TERN

Engineers Gate Manager’s Terns Pharmaceuticals TERN Stock Holding History

Engineers Gate Manager’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$521K Sell
9,880
-6,885
-41% -$283K 0.01% 1395
2025
Q4 		$677K Buy
+16,765
New +$387K 0.01% 1220
2025
Q3 		– Sell
-11,056
Closed -$41.2K – 2524
2025
Q2 		$41.2K Buy
+11,056
New +$34.5K ﹤0.01% 2061
2025
Q1 		– Sell
-64,666
Closed -$358K – 2577
2024
Q4 		$358K Buy
64,666
+32,298
+100% +$219K 0.01% 1630
2024
Q3 		$270K Sell
32,368
-7,172
-18% -$59K 0.01% 1666
2024
Q2 		$269K Buy
39,540
+22,274
+129% +$135K 0.01% 1519
2024
Q1 		$113K Buy
+17,266
New +$113K ﹤0.01% 1730

Other funds holding TERN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Engineers Gate Manager's TERN Position: Q1 2026 in Review

Engineers Gate Manager reduced its Terns Pharmaceuticals (TERN) stake by 41% in Q1 2026, selling an estimated $283K and leaving 9,880 shares worth $521K. The position accounts for 0.01% of the portfolio, ranked #1395.

Engineers Gate Manager first reported a position in TERN in Q1 2024 and has held it in 7 quarters since. The position peaked at $677K in Q4 2025. 317 funds tracked by Wall St. Rank hold TERN as of Q1 2026.

  • Engineers Gate Manager held 9,880 shares of Terns Pharmaceuticals worth $521K as of Q1 2026.
  • Engineers Gate Manager sold 6,885 Terns Pharmaceuticals shares in Q1 2026, an estimated $283K.
  • Terns Pharmaceuticals made up 0.01% of Engineers Gate Manager's portfolio in Q1 2026, its #1395 holding.
  • Engineers Gate Manager first reported a position in Terns Pharmaceuticals in Q1 2024 and has held it in 7 quarters since.
  • Engineers Gate Manager's Terns Pharmaceuticals position peaked at $677K in Q4 2025.
  • 317 funds tracked by Wall St. Rank held Terns Pharmaceuticals as of Q1 2026.

Based on Engineers Gate Manager's 13F filing for Q1 2026, filed 15 May 2026.